According to the National Cancer Institute, more than 17 million people were living with cancer in the United States, with treatment costs surpassing $200 billion in 2020. While advancements in medical technology have led to a decrease in cancer mortality rates, the number of diagnosed cases continues to rise. The American Cancer Society reports that 2024 is projected to be the first year the United States will see more than two million new cancer cases.
For over a century, high-dose systemic therapies like chemotherapy have been the cornerstone of cancer treatment. Although these drugs have been successful for some patients, they often compromise the immune system and come with severe adverse effects.
